Literature DB >> 21295589

Modeling the host response to inhalation anthrax.

Judy Day1, Avner Friedman, Larry S Schlesinger.   

Abstract

Inhalation anthrax, an often fatal infection, is initiated by endospores of the bacterium Bacillus anthracis, which are introduced into the lung. To better understand the pathogenesis of an inhalation anthrax infection, we propose a two-compartment mathematical model that takes into account the documented early events of such an infection. Anthrax spores, once inhaled, are readily taken up by alveolar phagocytes, which then migrate rather quickly out of the lung and into the thoracic/mediastinal lymph nodes. En route, these spores germinate to become vegetative bacteria. In the lymph nodes, the bacteria kill the host cells and are released into the extracellular environment where they can be disseminated into the blood stream and grow to a very high level, often resulting in the death of the infected person. Using this framework as the basis of our model, we explore the probability of survival of an infected individual. This is dependent on several factors, such as the rate of migration and germination events and treatment with antibiotics.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295589      PMCID: PMC3253853          DOI: 10.1016/j.jtbi.2011.01.054

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  57 in total

Review 1.  Recognition and management of anthrax--an update.

Authors:  M N Swartz
Journal:  N Engl J Med       Date:  2001-11-06       Impact factor: 91.245

2.  Mailborne transmission of anthrax: Modeling and implications.

Authors:  Glenn F Webb; Martin J Blaser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

3.  Emergency response to an anthrax attack.

Authors:  Lawrence M Wein; David L Craft; Edward H Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-21       Impact factor: 11.205

4.  Early Bacillus anthracis-macrophage interactions: intracellular survival survival and escape.

Authors:  T C Dixon; A A Fadl; T M Koehler; J A Swanson; P C Hanna
Journal:  Cell Microbiol       Date:  2000-12       Impact factor: 3.715

5.  Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha.

Authors:  R Pellizzari; C Guidi-Rontani; G Vitale; M Mock; C Montecucco
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

6.  Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

Authors:  Jennifer Gordon Wright; Conrad P Quinn; Sean Shadomy; Nancy Messonnier
Journal:  MMWR Recomm Rep       Date:  2010-07-23

7.  Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells.

Authors:  Serguei G Popov; Rafael Villasmil; Jessica Bernardi; Edith Grene; Jennifer Cardwell; Taissia Popova; Aiguo Wu; Darya Alibek; Charles Bailey; Ken Alibek
Journal:  FEBS Lett       Date:  2002-09-11       Impact factor: 4.124

8.  Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin.

Authors:  J L Erwin; L M DaSilva; S Bavari; S F Little; A M Friedlander; T C Chanh
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

9.  Lethal toxin of Bacillus anthracis causes apoptosis of macrophages.

Authors:  Serguei G Popov; Rafael Villasmil; Jessica Bernardi; Edith Grene; Jennifer Cardwell; Aiguo Wu; Darya Alibek; Charles Bailey; Ken Alibek
Journal:  Biochem Biophys Res Commun       Date:  2002-04-26       Impact factor: 3.575

Review 10.  The alveolar macrophage: the Trojan horse of Bacillus anthracis.

Authors:  Chantal Guidi-Rontani
Journal:  Trends Microbiol       Date:  2002-09       Impact factor: 17.079

View more
  8 in total

1.  Deterministic models of inhalational anthrax in New Zealand white rabbits.

Authors:  Bradford Gutting
Journal:  Biosecur Bioterror       Date:  2014-02-14

2.  Microbicidal power of alpha radiation in sterilizing germinating Bacillus anthracis spores.

Authors:  Johanna Rivera; Alfred Morgenstern; Frank Bruchertseifer; John F Kearney; Charles L Turnbough; Ekaterina Dadachova; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2013-12-30       Impact factor: 5.191

3.  Modeling early events in Francisella tularensis pathogenesis.

Authors:  Joseph J Gillard; Thomas R Laws; Grant Lythe; Carmen Molina-París
Journal:  Front Cell Infect Microbiol       Date:  2014-12-11       Impact factor: 5.293

4.  Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia.

Authors:  Bradford W Gutting; Tonya L Nichols; Stephen R Channel; Jeffery M Gearhart; George A Andrews; Alan E Berger; Ryan S Mackie; Brent J Watson; Sarah C Taft; Katie A Overheim; Robert L Sherwood
Journal:  Front Cell Infect Microbiol       Date:  2012-06-28       Impact factor: 5.293

Review 5.  Mathematical Models for Immunology: Current State of the Art and Future Research Directions.

Authors:  Raluca Eftimie; Joseph J Gillard; Doreen A Cantrell
Journal:  Bull Math Biol       Date:  2016-10-06       Impact factor: 1.758

6.  A mathematical model shows macrophages delay Staphylococcus aureus replication, but limitations in microbicidal capacity restrict bacterial clearance.

Authors:  Alex Best; Jamil Jubrail; Mike Boots; David Dockrell; Helen Marriott
Journal:  J Theor Biol       Date:  2020-04-15       Impact factor: 2.691

7.  A Novel Stochastic Multi-Scale Model of Francisella tularensis Infection to Predict Risk of Infection in a Laboratory.

Authors:  Jonathan Carruthers; Martín López-García; Joseph J Gillard; Thomas R Laws; Grant Lythe; Carmen Molina-París
Journal:  Front Microbiol       Date:  2018-07-06       Impact factor: 5.640

Review 8.  Dangerous Pathogens as a Potential Problem for Public Health.

Authors:  Edyta Janik; Michal Ceremuga; Marcin Niemcewicz; Michal Bijak
Journal:  Medicina (Kaunas)       Date:  2020-11-06       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.